• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道微生物群与艰难梭菌感染的清除有关,而与适应性免疫无关。

The Gut Microbiota Is Associated with Clearance of Clostridium difficile Infection Independent of Adaptive Immunity.

机构信息

Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, Michigan, USA.

Division of Infectious Diseases, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA.

出版信息

mSphere. 2019 Jan 30;4(1):e00698-18. doi: 10.1128/mSphereDirect.00698-18.

DOI:10.1128/mSphereDirect.00698-18
PMID:30700514
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6354811/
Abstract

() , a Gram-positive, anaerobic bacterium, is the leading single cause of nosocomial infections in the United States. A major risk factor for infection (CDI) is prior exposure to antibiotics, as they increase susceptibility to CDI by altering the membership of the microbial community enabling colonization. The importance of the gut microbiota in providing protection from CDI is underscored by the reported 80 to 90% success rate of fecal microbial transplants in treating recurrent infections. Adaptive immunity, specifically humoral immunity, is also sufficient to protect from both acute and recurrent CDI. However, the role of the adaptive immune system in mediating clearance of has yet to be resolved. Using murine models of CDI, we found that adaptive immunity is dispensable for clearance of However, random forest analysis using only two members of the resident bacterial community correctly identified animals that would go on to clear the infection with 66.7% accuracy. These findings indicate that the indigenous gut microbiota independent of adaptive immunity facilitates clearance of from the murine gastrointestinal tract. infection is a major cause of morbidity and mortality in hospitalized patients in the United States. Currently, the role of the adaptive immune response in modulating levels of colonization is unresolved. This work suggests that the indigenous gut microbiota is a main factor that promotes clearance of from the GI tract. Our results show that clearance of can occur without contributions from the adaptive immune response. This study also has implications for the design of preclinical studies testing the efficacy of vaccines on clearance of bacterial pathogens, as inherent differences in the baseline community structure of animals may bias findings.

摘要

艰难梭菌是一种革兰氏阳性、厌氧细菌,是美国医院获得性感染的主要单一病因。艰难梭菌感染(CDI)的一个主要危险因素是先前接触过抗生素,因为抗生素通过改变微生物群落的组成使易感性增加,从而导致 CDI。肠道微生物群在提供对 CDI 的保护方面的重要性,通过粪菌移植治疗复发性感染的 80%至 90%的成功率得到了强调。适应性免疫,特别是体液免疫,也足以预防急性和复发性 CDI。然而,适应性免疫系统在介导清除中的作用尚未得到解决。使用艰难梭菌感染的小鼠模型,我们发现适应性免疫对于清除是可有可无的。然而,仅使用常驻细菌群落的两个成员进行随机森林分析,可以以 66.7%的准确率正确识别出将清除感染的动物。这些发现表明,独立于适应性免疫的土著肠道微生物群有助于从鼠胃肠道中清除。艰难梭菌感染是美国住院患者发病率和死亡率的主要原因。目前,适应性免疫反应在调节 定植水平方面的作用尚未解决。这项工作表明,土著肠道微生物群是促进从胃肠道清除的主要因素。我们的研究结果表明,在没有适应性免疫反应的情况下,可以清除。这项研究对测试清除细菌病原体疫苗疗效的临床前研究的设计也具有影响,因为动物基线群落结构的固有差异可能会使研究结果产生偏差。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86b2/6354811/c5fac6a4dc8d/mSphereDirect.00698-18-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86b2/6354811/a571de1cbbb6/mSphereDirect.00698-18-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86b2/6354811/79523befa960/mSphereDirect.00698-18-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86b2/6354811/833613eae6a1/mSphereDirect.00698-18-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86b2/6354811/eabdb63024ef/mSphereDirect.00698-18-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86b2/6354811/c5fac6a4dc8d/mSphereDirect.00698-18-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86b2/6354811/a571de1cbbb6/mSphereDirect.00698-18-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86b2/6354811/79523befa960/mSphereDirect.00698-18-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86b2/6354811/833613eae6a1/mSphereDirect.00698-18-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86b2/6354811/eabdb63024ef/mSphereDirect.00698-18-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86b2/6354811/c5fac6a4dc8d/mSphereDirect.00698-18-f0005.jpg

相似文献

1
The Gut Microbiota Is Associated with Clearance of Clostridium difficile Infection Independent of Adaptive Immunity.肠道微生物群与艰难梭菌感染的清除有关,而与适应性免疫无关。
mSphere. 2019 Jan 30;4(1):e00698-18. doi: 10.1128/mSphereDirect.00698-18.
2
Alters the Structure and Metabolism of Distinct Cecal Microbiomes during Initial Infection To Promote Sustained Colonization.在初始感染期间改变不同盲肠微生物组的结构和代谢,以促进持续定植。
mSphere. 2018 Jun 27;3(3). doi: 10.1128/mSphere.00261-18.
3
Diluted Fecal Community Transplant Restores Clostridioides difficile Colonization Resistance to Antibiotic-Perturbed Murine Communities.稀释粪菌移植可恢复抗生素扰乱的小鼠群落中艰难梭菌的定植抗性。
mBio. 2022 Aug 30;13(4):e0136422. doi: 10.1128/mbio.01364-22. Epub 2022 Aug 1.
4
Clearance of Clostridioides difficile Colonization Is Associated with Antibiotic-Specific Bacterial Changes.艰难梭菌定植清除与抗生素特异性细菌变化相关。
mSphere. 2021 May 5;6(3):e01238-20. doi: 10.1128/mSphere.01238-20.
5
Pre-colonization with the commensal fungus Candida albicans reduces murine susceptibility to Clostridium difficile infection.定植前期的共生真菌白色念珠菌降低了小鼠对艰难梭菌感染的易感性。
Gut Microbes. 2018 Nov 2;9(6):497-509. doi: 10.1080/19490976.2018.1465158. Epub 2018 May 30.
6
Intestinal Inflammation and Altered Gut Microbiota Associated with Inflammatory Bowel Disease Render Mice Susceptible to Clostridioides difficile Colonization and Infection.肠道炎症和肠道微生物群改变与炎症性肠病相关,使小鼠易感染艰难梭菌定植和感染。
mBio. 2021 Jun 29;12(3):e0273320. doi: 10.1128/mBio.02733-20. Epub 2021 Jun 15.
7
Intestinal Inflammation Reversibly Alters the Microbiota to Drive Susceptibility to Clostridioides difficile Colonization in a Mouse Model of Colitis.肠道炎症可使微生物群发生可逆性改变,从而增加结肠炎小鼠对艰难梭菌定植的易感性。
mBio. 2022 Aug 30;13(4):e0190422. doi: 10.1128/mbio.01904-22. Epub 2022 Jul 28.
8
Protection from Lethal Clostridioides difficile Infection via Intraspecies Competition for Cogerminant.通过种内竞争共生体预防致命艰难梭菌感染。
mBio. 2021 Mar 30;12(2):e00522-21. doi: 10.1128/mBio.00522-21.
9
An Osmotic Laxative Renders Mice Susceptible to Prolonged Clostridioides difficile Colonization and Hinders Clearance.渗透性泻药使小鼠易受长时间艰难梭菌定植的影响,并阻碍其清除。
mSphere. 2021 Oct 27;6(5):e0062921. doi: 10.1128/mSphere.00629-21. Epub 2021 Sep 29.
10
Role of microbiota and innate immunity in recurrent Clostridium difficile infection.微生物群和先天免疫在复发性艰难梭菌感染中的作用。
J Immunol Res. 2014;2014:462740. doi: 10.1155/2014/462740. Epub 2014 Jun 5.

引用本文的文献

1
PREVENTION OF HEALTH CARE-ASSOCIATED INFECTIONS IN U.S. HEALTH SYSTEMS: HARNESSING THE GUT MICROBIOME TO COMBAT INFECTION.美国医疗系统中医疗保健相关感染的预防:利用肠道微生物群对抗感染。
Trans Am Clin Climatol Assoc. 2025;135:260-268.
2
. as a Potential Therapeutic Drug Intervention in Ulcerative Colitis: Mechanisms of Action and Clinical Studies.作为溃疡性结肠炎潜在的治疗性药物干预:作用机制与临床研究
Drug Des Devel Ther. 2024 Dec 11;18:5931-5946. doi: 10.2147/DDDT.S486407. eCollection 2024.
3
The state of play of rodent models for the study of infection.

本文引用的文献

1
OptiClust, an Improved Method for Assigning Amplicon-Based Sequence Data to Operational Taxonomic Units.OptiClust,一种将基于扩增子的序列数据分配到操作分类单元的改进方法。
mSphere. 2017 Mar 8;2(2). doi: 10.1128/mSphereDirect.00073-17. eCollection 2017 Mar-Apr.
2
Randomised clinical trial: faecal microbiota transplantation for recurrent Clostridum difficile infection - fresh, or frozen, or lyophilised microbiota from a small pool of healthy donors delivered by colonoscopy.随机临床试验:粪便微生物群移植治疗复发性艰难梭菌感染 - 来自一小批健康供体的新鲜、冷冻或冻干微生物群,通过结肠镜检查输送。
Aliment Pharmacol Ther. 2017 Apr;45(7):899-908. doi: 10.1111/apt.13969. Epub 2017 Feb 21.
3
啮齿动物模型在 感染研究中的应用现状。
J Med Microbiol. 2024 Jul;73(7). doi: 10.1099/jmm.0.001857.
4
Therapeutic Potential of Essential Oils Against Ulcerative Colitis: A Review.精油对溃疡性结肠炎的治疗潜力:综述
J Inflamm Res. 2024 May 31;17:3527-3549. doi: 10.2147/JIR.S461466. eCollection 2024.
5
IL-13 protects from Clostridioides difficile colitis.白细胞介素-13 可预防艰难梭菌结肠炎。
Anaerobe. 2024 Aug;88:102860. doi: 10.1016/j.anaerobe.2024.102860. Epub 2024 May 1.
6
Diluted Fecal Community Transplant Restores Clostridioides difficile Colonization Resistance to Antibiotic-Perturbed Murine Communities.稀释粪菌移植可恢复抗生素扰乱的小鼠群落中艰难梭菌的定植抗性。
mBio. 2022 Aug 30;13(4):e0136422. doi: 10.1128/mbio.01364-22. Epub 2022 Aug 1.
7
Capturing the environment of the Clostridioides difficile infection cycle.捕捉艰难梭菌感染周期的环境。
Nat Rev Gastroenterol Hepatol. 2022 Aug;19(8):508-520. doi: 10.1038/s41575-022-00610-0. Epub 2022 Apr 25.
8
A Multi-Factorial Observational Study on Sequential Fecal Microbiota Transplant in Patients with Medically Refractory Infection.序贯粪菌移植治疗药物难治性感染的多因素观察性研究。
Cells. 2021 Nov 19;10(11):3234. doi: 10.3390/cells10113234.
9
In vivo commensal control of Clostridioides difficile virulence.体内共生控制艰难梭菌毒力。
Cell Host Microbe. 2021 Nov 10;29(11):1693-1708.e7. doi: 10.1016/j.chom.2021.09.007. Epub 2021 Oct 11.
10
Protection from Lethal Clostridioides difficile Infection via Intraspecies Competition for Cogerminant.通过种内竞争共生体预防致命艰难梭菌感染。
mBio. 2021 Mar 30;12(2):e00522-21. doi: 10.1128/mBio.00522-21.
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection.
贝洛妥珠单抗预防复发性艰难梭菌感染。
N Engl J Med. 2017 Jan 26;376(4):305-317. doi: 10.1056/NEJMoa1602615.
4
A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice.阿克曼氏菌黏液亚种的纯化膜蛋白或巴氏杀菌细菌可改善肥胖和糖尿病小鼠的代谢。
Nat Med. 2017 Jan;23(1):107-113. doi: 10.1038/nm.4236. Epub 2016 Nov 28.
5
The parameter sensitivity of random forests.随机森林的参数敏感性。
BMC Bioinformatics. 2016 Sep 1;17(1):331. doi: 10.1186/s12859-016-1228-x.
6
Accounting for reciprocal host-microbiome interactions in experimental science.在实验科学中考虑宿主-微生物组的相互作用。
Nature. 2016 Jun 9;534(7606):191-9. doi: 10.1038/nature18285.
7
Antibiotic-Induced Alterations of the Gut Microbiota Alter Secondary Bile Acid Production and Allow for Clostridium difficile Spore Germination and Outgrowth in the Large Intestine.抗生素诱导的肠道微生物群改变会改变次级胆汁酸的产生,并允许艰难梭菌孢子在大肠中发芽和生长。
mSphere. 2016 Jan 6;1(1). doi: 10.1128/mSphere.00045-15. eCollection 2016 Jan-Feb.
8
Gut microbiota, metabolites and host immunity.肠道微生物群、代谢产物与宿主免疫
Nat Rev Immunol. 2016 May 27;16(6):341-52. doi: 10.1038/nri.2016.42.
9
Risk factors for Clostridium difficile infection in hospitalized patients with community-acquired pneumonia.社区获得性肺炎住院患者中艰难梭菌感染的危险因素。
J Infect. 2016 Jul;73(1):45-53. doi: 10.1016/j.jinf.2016.04.008. Epub 2016 Apr 19.
10
Immunogenicity and protective efficacy of recombinant Clostridium difficile flagellar protein FliC.重组艰难梭菌鞭毛蛋白FliC的免疫原性和保护效力
Emerg Microbes Infect. 2016 Feb 3;5(2):e8. doi: 10.1038/emi.2016.8.